| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 778 | 597 |
| Effect of exchange rate changes on cash and cash equivalents | -333 | -688 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 5,648 | 4,563 |
| Cash and cash equivalents at beginning of period | 71,162 | - |
| Cash and cash equivalents at end of period | 76,810 | - |
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)